Free tool
Heavily traded stocks
We cover 6 companies whose typical session turns over more than $10.00M. The median market value in the group is $14.72B. Across the group, the median move over the past trading day is +1.45%. Price change over the past year runs from +12.6% to +890.9% across the middle 80 percent of the group, with a median of +34.1%.
Other lists in this group
Table
6 of 7,336 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return | Next report |
|---|---|---|---|---|---|
| TMO | Thermo Fisher Scientific Inc. | $234.31B | Mega cap | +30.17% | Oct 21, 2026 |
| ARGX | argenx SE | $65.51B | Large cap | +47.90% | Oct 22, 2026 |
| DGX | Quest Diagnostics Incorporated | $26.99B | Large cap | +38.12% | Oct 20, 2026 |
| ATRC | AtriCure, Inc. | $2.45B | Mid cap | +29.14% | Oct 27, 2026 |
| CHEMM.CO | ChemoMetec A/S | $1.33B | Small cap | −3.94% | Sep 10, 2026 |
| CRNA.OL | Circio Holding ASA | $384.19M | Small cap | +1733.85% | Aug 31, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.